Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$846M |
| 2 |
JD.com
JD
|
+$782M |
| 3 |
Dollar General
DG
|
+$647M |
| 4 |
Monster Beverage
MNST
|
+$324M |
| 5 |
NXP Semiconductors
NXPI
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$668M |
| 2 |
Mondelez International
MDLZ
|
+$528M |
| 3 |
Alibaba
BABA
|
+$457M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$409M |
| 5 |
CELG
Celgene Corp
CELG
|
+$403M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.97% |
| 2 | Consumer Discretionary | 16.01% |
| 3 | Technology | 12.95% |
| 4 | Communication Services | 12.43% |
| 5 | Financials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Eli Lilly
LLY
$1.08T
| $87.9M | 0.08% |
1,052,905
+8,569
| +0.8% | +$653K |
|
|
PPL
227
PPL Corp
PPL
$26.9B
| $87.4M | 0.08% |
2,965,330
-691,180
| -19% | -$21.6M |
|
228
Range Resources
RRC
$9.33B
| $86.8M | 0.08% |
1,757,234
+112,822
| +7% | +$6.44M |
|
229
American Electric Power
AEP
$70.4B
| $86.7M | 0.08% |
1,637,468
-284,216
| -15% | -$15.7M |
|
|
EQGP
230
DELISTED
EQGP Holdings, LP
EQGP
| $86.7M | 0.08% |
+2,550,172
| New | +$83.2M |
|
231
McKesson
MCK
$104B
| $85.9M | 0.08% |
382,243
+3,304
| +0.9% | +$764K |
|
|
AET
232
DELISTED
Aetna Inc
AET
| $85.6M | 0.08% |
671,229
-4,205
| -0.6% | -$480K |
|
233
AstraZeneca
AZN
$269B
| $85.5M | 0.08% |
1,342,507
+11,578
| +0.9% | +$793K |
|
|
EMC
234
DELISTED
EMC CORPORATION
EMC
| $85.5M | 0.08% |
3,238,710
+61,628
| +2% | +$1.64M |
|
|
BLUE
235
DELISTED
bluebird bio
BLUE
| $85.4M | 0.08% |
39,141
-6,355
| -14% | -$12.9M |
|
236
Wintrust Financial
WTFC
$10.7B
| $84.6M | 0.08% |
1,585,079
+150,148
| +10% | +$7.56M |
|
|
CPN
237
DELISTED
Calpine Corporation
CPN
| $84.3M | 0.08% |
4,687,080
+527
| +0% | +$11K |
|
238
Bankunited
BKU
$3.33B
| $83.9M | 0.08% |
2,334,357
+27,057
| +1% | +$923K |
|
239
Artisan Partners
APAM
$2.86B
| $83.4M | 0.08% |
1,795,108
-55,756
| -3% | -$2.55M |
|
|
ICPT
240
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $83.4M | 0.08% |
345,366
-120,096
| -26% | -$32M |
|
|
GOLD
241
DELISTED
Randgold Resources Ltd
GOLD
| $81.8M | 0.08% |
1,230,622
+8,944
| +0.7% | +$647K |
|
242
DTE Energy
DTE
$29.9B
| $81.2M | 0.07% |
1,278,854
-114,892
| -8% | -$7.68M |
|
243
Digital Realty Trust
DLR
$69.6B
| $80.3M | 0.07% |
1,203,988
-191,585
| -14% | -$12.6M |
|
244
Thermo Fisher Scientific
TMO
$214B
| $79.7M | 0.07% |
614,162
+55,528
| +10% | +$7.24M |
|
245
Copart
CPRT
$28.5B
| $79.2M | 0.07% |
17,862,488
-653,416
| -4% | -$2.95M |
|
|
AIRM
246
DELISTED
Air Methods Corp
AIRM
| $78.1M | 0.07% |
1,888,106
+149,622
| +9% | +$6.55M |
|
247
Adecoagro
AGRO
$1.4B
| $77.9M | 0.07% |
8,452,238
+352,735
| +4% | +$3.51M |
|
248
Constellium
CSTM
$3.76B
| $77.9M | 0.07% |
6,584,459
-864,983
| -12% | -$13.6M |
|
|
CLDT
249
Chatham Lodging
CLDT
$632M
| $77.4M | 0.07% |
2,925,501
+825,458
| +39% | +$23.2M |
|
|
CPPL
250
DELISTED
Columbia Pipeline Partners LP
CPPL
| $77.4M | 0.07% |
3,072,893
+8,345
| +0.3% | +$224K |
|
Similar funds
Jennison Associates's Q2 2015 Portfolio in Review
As of Q2 2015, Jennison Associates held 801 positions worth $109B, down 0.05% from $109B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Jennison Associates's Q2 2015 filing shows 92 new, 315 increased, 305 reduced and 72 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 1,732,726 shares worth $884M. The largest sale was Union Pacific, an estimated $668M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Technology.
- Jennison Associates's largest Q2 2015 buy was Regeneron Pharmaceuticals: 1,732,726 shares worth $884M.
- Jennison Associates added most to JD.com in Q2 2015, an estimated $782M increase.
- Jennison Associates's biggest Q2 2015 reduction was Union Pacific, cutting an estimated $668M.
- Jennison Associates fully exited Perrigo in Q2 2015, selling an estimated $204M.
- Jennison Associates's ten largest holdings make up 21% of its $109B portfolio in Q2 2015.
- Jennison Associates opened 92 new positions and closed 72 in Q2 2015.
- Jennison Associates's portfolio value fell 0.05% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q2 2015, filed 3 Aug 2015.